NNVC Recent News Triphase Receives FDA Orphan Dru

NNVC Recent News

Triphase Receives FDA Orphan Drug Designation for Marizomib in Multiple Myeloma Business Wire - Thu Feb 27, 7:01AM CST
NanoViricides, Inc. Reports its President & Chairman Dr. Diwan Purchased its Common Stock in the Open Market Business Wire - Wed Feb 26, 6:00AM CST
INVESTOR ALERT: Investigation of NanoViricides, Inc. Announced by Glancy Binkow & Goldberg LLP Business Wire - Tue Feb 25, 5:32PM CST
NanoViricides Reports that it is Evaluating Purchase of the New Facility and cGMP Pilot Production Plant instead of a Lease Business Wire - Thu Feb 20, 6:00AM CST
NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Two Drug Candidates Business Wire - Tue Feb 18, 6:00AM CST
5 of Last Week's Biggest Losers Motley Fool - Sun Feb 16, 9:30AM CST
NanoViricides, Inc. Demands Retraction of the Baseless and Inaccurate Libelous Article by an Anonymous Short Seller Posted on SeekingAlpha Website Business Wire - Fri Feb 14, 9:06AM CST
Harwood Feffer LLP Announces Investigation of NanoViricides, Inc. PR Newswire - Wed Feb 12, 7:30PM CST
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of NanoViricides, Inc. Business Wire - Wed Feb 12, 4:32PM CST